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 The majority of nanoparticle research, to date, has been
carried out by materials scientists, but recent trends have
brought these tools into the hands of biologists. Nanoparticles
have found two broad niches in biology, detection technolo-
gies and payload delivery [1,2]. Since the late 1970s,
nanoparticles have been used to deliver drugs [2,3]. In fact,
the majority of publications concerning biological applications
of nanoparticles are focused on the delivery of chemothera-
peutic agents with nanoparticles ranging from 2 to 3000 nm.
Nanoparticle mediated gene delivery has recently emerged as
a promising tool for gene therapy strategies [4-6]. The main
problems with using nanoparticles for gene delivery are the
construction, cost, and quality control of the nanoparticles
themselves. The construction quickly becomes very compli-
cated when the number of layers increases. This is due to the
interactions between layers and between nanoparticles with
incomplete and complete layering. These factors limit the use-
fulness of nanotechnology to laboratories that have chemists
capable of nanoparticle synthesis or to investigators in col-
laboration with chemists. This limits the technology, especially
for small laboratories. This study documents the development
of a streptavidin nanoparticle system that is simple and quite
flexible from a commercially available product intended for
other uses.
Magnetic nanoparticles have been primarily applied to
three fields: magnetic resonance imaging, molecular and cell
separation technologies, and drug delivery [7-11]. Many re-
searchers use magnetic particles as contrast agents [12-16].
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Purpose: Layered nanoparticles have the potential to deliver any number of substances to cells both in vitro and in vivo.
The purpose of this study was to develop and test a relatively simple alternative to custom synthesized nanoparticles for
use in multiple biological systems, with special focus on the eye.
Methods: The biotin-labeled transcriptionally active PCR products (TAP) were conjugated to gold, semiconductor
nanocrystals, and magnetic nanoparticles (MNP) coated with streptavidin. The process of nanoparticle construction was
monitored with gel electrophoresis. Fluorescence microscopy followed by image analysis was used to examine gene
expression levels from DNA alone and tethered MNP in human hepatoma derived Huh-7 cells. Adult retinal endothelial
cells from both dog (ADREC) and human (HREC) sources were transfected with nanoparticles and reporter gene expres-
sion evaluated with confocal and fluorescent microscopy. Transmission electron microscopy was used to quantify the
concentration of nanoparticles in a stock solution. Nanoparticles were evaluated for transfection efficiency, determined by
fluorescence microscopy cell counts. Cells treated with MNP were evaluated for increased reactive oxygen species (ROS)
and necrosis with flow cytometry.
Results: Both 5' and 3' biotin-labeled TAP bound equally to MNP and there were no differences in functionality between
the two tethering orientations. Free DNA was easily removed by the use of magnetic columns. These particles were also
able to deliver genes to a human hepatoma cell line, Huh-7, but transfection efficiency was greater than TAP. The semi-
conductor nanocrystals and MNP had the highest transfection efficiencies. The MNP did not induce ROS formation or
necrosis after 48 h of incubation.
Conclusions: Once transfected, the MNP had reporter gene expression levels equivalent to TAP. The nanoparticles, how-
ever, had better transfection efficiencies than TAP. The magnetic nanoparticles were the most easily purified of all the
nanoparticles tested. This strategy for bioconjugating TAP to nanoparticles is valuable because nanoparticle composition
can be changed and the system optimized quickly. Since endothelial cells take up MNP, this strategy could be used to
target neovascularization as occurs in proliferative retinopathies. Multiple cell types were used to test this technology and
in each the nanoparticles were capable of transfection. In adult endothelial cells the MNP appeared innocuous, even at the
highest doses tested with respect to ROS and necrosis. This technology has the potential to be used as more than just a
vector for gene transfer, because each layer has the potential to perform its own unique function and then degrade to
expose the next functional layer.
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Because these agents are used primarily in diagnostic in vivo
imaging, many of the particle formulations are already ap-
proved for use in humans. The magnetic properties of these
particles are quite favorable for layered construction of a
nonviral based gene delivery vector.
We are currently developing a nanomedicine strategy to
prevent retinopathy of prematurity (ROP) [17], a disease in
which it would be undesirable to use a viral gene delivery
system in premature infants. Our strategy is to deliver a
nanoparticle to a cell in the eye that is capable of detecting
and reacting to the initial hyperoxic insult that is the first stage
of ROP, vaso-obliteration [17]. This event will trigger the ex-
pression of a therapeutic gene able to save the cells in the eye
that would normally die and leave the retina with a compro-
mised vasculature. Before this can be accomplished, however
there are many challenges to overcome.
One of the most difficult challenges facing researchers
constructing layered nanoparticles is the purification of the
particles after each step. With magnetic particles, the purifi-
cation is generally simple and utilizes magnetic columns. The
magnetic properties of nanoparticles have been used to en-
hance gene transfer for gene therapy applications [18-22]. In
this case, the nanoparticles were used to concentrate the plas-
mid to a specific location and thereby increase the likelihood
of transfection [22]. The Plank lab used clusters of plasmid
DNA and coated magnetic nanoparticles were used to target
cells using the magnetic properties of the nanoparticle clus-
ters [18].
Several nanoparticle cores were investigated in this study,
including gold, semiconductor nanocrystals, and magnetic iron
oxide. Gold nanoparticles have traditionally been used as for
immunolabeling in transmission electron microscopy and are
commercially available in a variety of sizes. We chose to evalu-
ate one of the smaller gold nanoparticles (5 nm) available with
streptavidin already conjugated to the surface. Semiconduc-
tor nanocrystals are about 25 nm in diameter and have very
unique optical properties. These nanoparticles do not
photobleach, fluoresce intensely with UV excitation, and are
capable of having streptavidin bioconjugated to their surface
[23].
Superparamagnetic nanoparticle cores coated with dext-
ran bioconjugated to streptavidin were chosen for gene trans-
fer because they were easily obtainable, simple to construct
and could be purified from the unbound layer components
using magnetic columns. The core particles are composed of
an iron oxide core coated with dextran and bioconjugated to
streptavidin, with the complete particle measuring approxi-
mately 100 nm in diameter. We have developed a simple pro-
cedure for DNA conjugation, purification, and delivery to cells.
These particles were found to have reasonable transfection
efficiency, with respect to free DNA, when coated with lipid.
Genes were expressed from magnetic nanoparticles at levels
slightly below that of free DNA. Magnetic nanoparticles were
capable of transfecting several cell types including an immor-
talized human hepatoma cell line, Huh-7, and adult retinal
endothelial cells from both dog (ADREC) and human (HREC)
sources. This study demonstrates that the magnetic and semi-
conductor nanoparticles were the two largest and most effi-
cient for transfecting ADREC. Finally, the magnetic
nanoparticles alone did not induce oxidative stress or necrosis
as determined by flow cytometry.
METHODS
Biotin-labeled DNA fragment preparation:  PCR amplifica-
tion was used to create biotin-labeled DNA fragments. Oligo-
nucleotide primers were purchased from Integrated DNA Tech-
nologies, Inc. For initial studies, either the 5' or the 3' oligo
was made with a single biotin tag. The sequences were based
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Figure 1. Construction and purification of DNA tethered magnetic nanoparticles.  Gel electrophoresis was used to examine the successful
construction of the DNA tethered magnetic nanoparticles and to verify that the purification removed the unbound DNA from the nanoparticles.
Lanes A-C represent only DNA fragments. Lanes D-F contain the MNP/DNA mixture. After washing with a magnetic column, a portion of the
purified MNP were also run on this gel (Lanes G-I). On the right is a magnified image of the box around Lanes F-I. This gel shows three critical
stages of nanoparticle construction, DNA alone, DNA tethered nanoparticle in excess DNA, and finally DNA tethered nanoparticles free of
unbound DNA.
607
on the pEGFP-C1 (BD Clontech, Inc., Mountain View, CA)
template: forward 5'-TAG TTA TTA ATA GTA ATC AAT TAC
GGG GTC ATT AG-3', reverse 5'-TAC ATT GAT GAG TTT
GGA CAA ACC ACA ACT AGA AT-3' (Integrated DNA Tech-
nologies, Inc., Coralville, IA). The forward primer begins on
the first nucleotide of the CMV promoter (red thymine),
whereas the reverse primer is past the last nucleotide of the
SV40 polyadenylation signal. Thus all of the components nec-
essary for gene expression are present in the PCR product.
Later studies used only 5' oligonucleotides labeled with bi-
otin. These oligonucleotides were then used as PCR primers.
A typical reaction would include 25 µl Red Taq, (Sigma, Inc.,
St. Louis, MO), 1 µl 5' biotinylated primer, 1 µl 3' primer, 1 µl
template, to 50 µl with water. The primers were at 200 pM
and the template at 50 ng/µl. A typical reaction for DNA teth-
ering to magnetic nanoparticles would include 25 of these re-
actions combined. Typical PCR cycles would include about
35 cycles of denaturing temperature at 94 °C for 30 s, anneal-
ing temperature at 65 °C for 30 s and extension for 2 min at 72
°C.
DNA tethered nanoparticle construction:  Biotin-labeled
PCR products were tethered to streptavidin-coated magnetic
nanoparticles (Miltenyi Biotech, Inc., Auburn, CA). This
nanoparticle has an iron oxide core coated with dextran that is
bioconjugated to streptavidin. DNA tethered magnetic
nanoparticles were constructed by incubating the magnetic
nanoparticles with the biotin-labeled PCR fragments at the
ratio of 31 ng DNA to 1 µl of nanoparticles. The mixture was
incubator at room temperature for 30 min. During that time,
the magnetic column was prepared by washing once with the
100 µl of the nucleic acid buffer and three times with 100 µl
of Optimem (Gibco, Inc., Rockville, MD). Once washed, the
column was loaded with the DNA nanoparticle mixture. The
column was then washed three times with 100 µl Optimem.
The nanoparticles were eluted by removing the column from
the magnet and adding the 100 µl of Optimem. The resulting
brownish solution contained DNA tethered nanoparticles.
The amount of transcriptionally active PCR products
(TAP) bound per µl of streptavidin-Cy3 (SA), gold
nanoparticles (GNP), nanocrystals (NC; made by the Kotov
lab or purchased from Quantum Dot, Inc., Hayward, CA), and
MNP was determined by gel electrophoresis. An excess of
TAP was added to 10 µl of the nanoparticle stock solution and
incubated at room temperature for 20 min. The maximal
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Figure 2. Adult dog retinal epithelium cells cytotoxicity from un-
coated magnetic nanoparticles.  The images are representative phase
contrast photomicrographs of ADREC treated with 0 ng (A) or 400
ng (B) DNA tethered MNP without lipid-coating for 24 h. C: The
effects of uncoated magnetic nanoparticles (0, 200, 400, 1000 ng
DNA equivalents) on reactive oxygen species (ROS; white bars) and
necrosis (red bars) after 48 h incubation. 100 µM tert-butyl hydro-
gen peroxide was used as a positive control. The error bars represent
standard deviation. One potential cause for concern when using iron
derived nanoparticles is iron induced oxidative stress, while another
concern may be membrane integrity. Therefore, an oxidative stress
sensitive fluorescent dye was used to confirm the absence of
nanoparticle induced oxidative stress. Likewise, propidium iodide
was used to confirm the absence of ruptured membrane. Flow
cytometric analysis of these cells confirmed that there was no in-
crease in oxidative stress or ruptured membranes (Necrosis).
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amount of TAP bound per µl of SA, GNP, NC, and MNP was
determined by semi-quantitative gel electrophoresis to be 37.4,
16.9, 54.4, and 31.1 ng per µl, respectively. Therefore, 100 ng
TAP would bind 2.7 µl SA, 5.9 µl GNP, 1.8 µl NC, and 3.2 µl
MNP.
Lipid coating of DNA tethered magnetic nanoparticles:
The DNA tethered nanoparticles (400 ng DNA/13 µl MNP)
were coated with Lipofectamine 2000. The eluted particles
were diluted in the 250 µl of Optimem and incubated for 5
min at room temperature. 10 µl of Lipofectamine 2000 was
diluted with 250 µl of Optimem in a separate tube and incu-
bated at room temperature for 5 min. After 5 min, the two
tubes were mixed gently and combined. This mixture was al-
lowed to stand for 20 min before adding to the cell culture. All
nanoparticles had lipid coating except those in Figure 1, Fig-
ure 2B, and Figure 3 (as noted on the x-axis).
Confocal and fluorescence microscopy:  Cells were ex-
amined for reporter gene expression with a Zeiss 510META
confocal microscope. The two types of nanocrystals used for
these studies had 525 and 565 nm emission peaks. After exci-
tation with a 405 nm diode laser the emission light was passed
through a 490 nm long pass filter and finally detected with
520 nm and 560 nm bandpass filters for the 525 and 565 nm
nanocrystals, respectively. EGFP was excited with a 488 nm
argon ion laser and the emission light was passed through a
490 nm long pass filter and finally detected with a 520 nm
bandpass filter. DsRed was excited with a 543 nm HeNe laser
and the emission light was passed through a 490 nm long pass
filter and finally detected with a 560 nm bandpass filter. Dif-
ferential interference contrast (DIC) microscopy was also used
to image all cells using the 488 nm argon ion line.
Fluorescence microscopy was performed using a Nikon
Eclipse TE2000-U inverted microscope. Photomicrographs
were taken with a SPOT RT SE digital camera, Diagnostic
Instruments, Inc. (Sterling Heights, MI). Nanocrystals were
imaged using a Nikon Fluorogold filter set, which excites with
UV and contains a 505 nm long pass emission filter. EGFP
was imaged with a standard Nikon FITC filter set, while DsRed
was imaged using a standard Nikon Cy3 filter set.
Image analysis for gene expression levels:  A standard
wave-propagation algorithm was used to segment the images
over a singular threshold. Upper and lower boundaries were
chosen for subsegmentation. Segments which fell below the
lower area bound were removed. Segments which were above
the upper boundary were re-segmented with a higher thresh-
old and reexamined. The threshold level was computed as the
average of the intensity of the pixels within the segment mi-
nus the standard deviation of the intensity of the pixels bounded
below by zero. Threshold levels are computed individually
for each subsegment. The output is a list of segments associ-
ated with a bitmap representing the segment, the total inten-
sity, area, and standard deviation of intensity for that segment
[24].
Cell culture:  Cells were incubated at 37 °C in 5% CO2.
The Huh-7 cell line, derived from a human hepatoma (gift
from Rene Rijnbrand, University of Texas Medical Branch,
Galveston, TX), was cultured in DMEM supplemented with
10% FBS (Sigma, Inc.) and penicillin/streptomycin (Sigma).
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Figure 3. Expression levels of en-
hanced green fluorescent protein
from lipid-coated and uncoated
DNA tethered magnetic
nanoparticles.  In vitro gene expres-
sion levels are shown as the percent-
age of lipofectamine-transfected
enhanced green fluorescent protein
DNA. Biotin tagged DNA was also
transfected into cells. All samples
were incubated with or without
lipofectamine 2000.
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Each experiment was done at least in triplicate and positive
and negative controls were present in all experiments.
Primary cell lines of ADREC were established as reported
by Lutty et al. [25]. Adult beagles were euthanized by an in-
traperitoneal overdose of pentobarbital sodium. Animals were
treated in accordance with the ARVO Statement for the Use
of Animals in Ophthalmic and Vision Research. The eyes were
enucleated and placed in cold, sterile PBS and excess tissue
was cleared away. The eyes were then soaked in cold Betadine
for 15 min. The retina was washed thoroughly and homog-
enized in PBS, with a Dounce homogenizer. The homogenate
was filtered with a 105 µm Nitex nylon mesh in a porcelain
funnel under a gentle vacuum. The filtrate was then passed
through a 58 µm Nitex mesh. The vessel retentate was di-
gested in 0.375% collagenase and 0.25% bovine serum albu-
min in PBS for 45-60 min at 37 °C. The digestion was then
stopped by the addition of DMEM/F12 media supplemented
with 10% fetal bovine serum, 1% penicillin/streptomycin/
fungizone (Gibco, Inc.). The cells were then incubated at 37
°C in 5% CO2 for 24 h in a T-25 flask. After 24 h, the unat-
tached cells and debris were washed away and the remaining
cells were fed fresh media. All studies were done with cells at
less than passage 10. The endothelial cells used in these stud-
ies were vWF positive and took up Acetylated LDL.
Human retinal endothelial cells were purchased from Cell
Systems, Inc. (Kirkland, WA). These cells were maintained
on CSC medium from Cell Systems, Inc. Later, however, the
cells were successfully grown and split in the same fashion
and with the same medium as the ADREC above.
Cytotoxicity of magnetic nanoparticles:  Cytotoxicity was
evaluated by morphological analysis of ADREC incubated with
MNP for 24 h at several concentrations including, 0, 200, 400,
4000, and >15,000 ng of DNA. After incubation, the cells were
photographed under phase illumination as described above.
Reactive oxygen species formation after nanoparticle treat-
ment was determined by treating AREC with 0, 200, 400, and
1000 ng DNA equivalents of MNP (nanoparticles without DNA
or lipid coating) for 48 h. After incubation with the
nanoparticles, the cells were washed three times in PBS and
trypsinized to attain a cell suspension and stained with 50 µm/
ml propidium iodide (Sigma) for 10 min in DMEM/F12 at 37
°C in 5% CO2. After staining the cells were washed three times
with PBS. Next, the cells were stained with 5-(and 6-
)chloromethyl-2',7'-dichlorodihydrofluorescein diacetate,
acetyl ester (CM-H2DCFDA) in DMEM/F12 at 5 µM for 30
min under culture conditions. After CM-H2DCFDA staining,
the cells were washed three times in PBS and trypsinized to
attain a cell suspension. The cells were then washed three times
in complete media without phenol red. As a positive control
some cells were treated with 100 µM tert-butyl hydrogen per-
oxide for 30 min prior to staining. The cells were analyzed on
a FACScalibur flow cytometer, and data were analyzed by
CellQuest software (both from Becton Dickinson
Immunocytometry Systems, San Jose, CA).
Magnetic nanoparticle quantification with transmission
electron microscopy (TEM):  The stock solution of MNP was
purchased from Miltenyi Biotech, Inc. MNP stock solution
(10 µl) was diluted 1:100,000 with PBS. The diluted MNP
were then incubated with ten µl of biotin coated polystyrene
beads (1.75 million beads, 3.27 µm diameter from Spherotech,
Inc., Libertyville, IL) in 990 µl of PBS for 30 min at room
temperature. After 30 min, the beads were washed three times
in PBS by centrifugation at 1500 RPM in a Beckman TJ-6
centrifuge with a TH-4 1-88 rotor for 5 min. After washing,
the beads were fixed in fresh, 2% paraformaldehyde for 10
min. The beads were then dried overnight in a Savant SpeedVac
concentrator SVC100H. The beads were then mixed with
LX112 polymer (Ladd Research Industries, Inc., Burlington,
VT) and the solution placed in a cylindrical block mold in a
heated block form (Pelco International, Inc., Redding, CA)
and polymerized at 60 °C for 36 h. Thin sections (95 nm)
were cut on a Leica Ultracut UTC ultramicrotome and col-
lected on 150 mesh uncoated copper grids. Samples were
viewed and photographed with a JEOL 100CX TEM (JEOL
USA, Inc., Peabody, MA). NIH Image was used to determine
the area of the bead (n=90). The area and section thickness of
the beads were used to calculate the surface area of the cylin-
der (2πr2) exposed to nanoparticles. Nanoparticles were also
quantified and the data used to calculate the number of
nanoparticles per micrometer squared. This was then used to
determine the number of nanoparticles per µl (40 million).
RESULTS
Conjugation of DNA to magnetic nanoparticles:  Biotin-la-
beled PCR primers were used to generate CMV-EGFP-pA
(CMV promoter, EGFP reporter gene, and poly A signal) con-
taining DNA fragments (1.5 kb) with 5' biotin-labeled, 3' bi-
otin-labeled, or unlabeled. Streptavidin-coated magnetic
nanoparticles were incubated with each of the DNA fragments,
and no Lipofectamine, and analyzed by agarose gel electro-
phoresis (Figure 1). Figure 1 lanes A to C contained only the
PCR product. Figure 1 lanes D and F contained magnetic
nanoparticles incubated with the PCR fragments. DNA in Fig-
ure 1 lanes C and F contained no biotin tag and were, there-
fore, used as negative controls. The black square indicates in-
creased molecular weight DNA. The dark staining seen at the
top of Figure 1 lanes D and E indicate that the DNA was able
to bind to magnetic nanoparticles and was now trapped at the
top of the gel due to its large size. This gel also shows that
there is a significant amount of unbound DNA present. Be-
cause of this, the magnetic nanoparticles need to be purified
from the contaminating free DNA fragments as described in
the next section.
The MNP’s were the only nanoparticles capable of being
easily separated from unbound DNA. Therefore, the other
streptavidin-tagged nanoparticles used in this study had to be
incubated with the correct amount of DNA so as to avoid
nanoparticles without DNA and free DNA. This binding ratio
of nanoparticle to DNA was determined for each nanoparticle
and streptavidin by semiquantitative gel electrophoresis (data
not shown). Nanoparticles and streptavidin were individually
incubated with a known excess of 5' biotin labeled TAP. This
mixture was then electrophoresed on an agarose gel similar to
that shown in Figure 1. The amount of unbound TAP was de-
610
termined in a semiquantitative nature. The maximal amount
of TAP bound per µl of SA, GNP, NC, and MNP was deter-
mined by semi-quantitative gel electrophoresis to be 37.4, 16.9,
54.4, and 31.1 ng per µl, respectively. Therefore, 100 ng TAP
would bind 2.7 µl SA, 5.9 µl GNP, 1.8 µl NC, and 3.2 µl
MNP.
Removal of free DNA from magnetic nanoparticle/DNA
solutions:  In these experiments, the mixtures of DNA and
magnetic nanoparticles were washed four times to remove
unbound DNA using a magnetic column. It was found that the
magnetic properties of these particles enabled the rapid puri-
fication of the magnetic nanoparticles from the DNA solu-
tion. These samples were then run on an agarose gel (Figure
1). Figure 1 lanes A and C represent only DNA fragments.
Figure 1 lanes D and F contain the magnetic nanoparticle/
DNA mixture. After washing, a portion of the magnetic
nanoparticles were run onto this gel (Figure 1 lanes G and I).
If carefully examined (inset) dark staining can be seen only in
Figure 1 lanes G and H near the loading well. This suggests
that the free DNA has been removed and only the DNA teth-
ered magnetic nanoparticles remain in solution.
Cytotoxicity of uncoated magnetic nanoparticles in adult
dog retinal endothelial cells:  Adult dog retinal endothelial
cells (ADREC) were treated with increasing concentrations
of non-lipid-coated MNP and examined for signs of cytotox-
icity. As seen in Figure 2, there are no differences in cells
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Figure 4. Transfection efficiencies of lipid-coated magnetic
nanoparticles in adult dog retinal endothelial cells.  Three different
concentrations of transcriptionally active PCR products (TAP; white
bars) were used (100, 200, and 400 ng per well of 24 well plates)
either alone or tethered to lipid-coated nanoparticles (MNP; red bars).
Approximately 1000 cells were analyzed for each data point. The
bars represent the mean of 3 wells; the error bars represent the stan-
dard error of the mean. These data show that TAP tethered magnetic
nanoparticles are better at transfecting cells than free TAP in the 200
and 400 ng groups.
Figure 5. Transfection efficiencies of multiple lipid-coated nanoparticle sizes and cores.  Five transfection groups, including DNA alone,
streptavin-Cy3 (SA), 5 nm gold nanoparticles (GNP), 25 nm semiconductor nanocrystals (NC), and 100 nm magnetic nanoparticles (MNP),
were tested at three different DNA concentrations (100, 200, and 400 ng). All values were normalized to the 400 ng DNA alone group and all
groups were coated with lipid. The 400 ng MNP group had statistically significant greater transfection (p<0.01), when compared to the 400 ng
DNA alone, SA, GNP, or the NC groups using the Student’s t-test.
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exposed to MNP versus the untreated control. There are no
apparent signs of cytotoxicity, including pycnosis, blebbing,
or detachment. All of these cells appeared normal from the
beginning of the experiment to the end and were treated with
several concentrations of MNP ranging from 0 to the stock
concentration (40 million MNP per µl), which was dark brown.
Uncoated magnetic nanoparticles with no lipid coating were
tested for their ability to induce ROS formation or necrosis in
ADREC after incubation for 48 h. One hundred µM tert-butyl
hydrogen peroxide was added to the cells for 30 min prior to
flow cytometric analysis and was used as a positive control.
The results from this experiment are summarized in the graph
in Figure 2C. The three groups of cells treated with
nanoparticles were equivalent to the untreated control (0) with
respect to both ROS and necrosis. The positive control values
were substantially greater than any of the treatment groups. In
fact in all of the treatment groups, the number of positive cells
was approximately 5%.
Expression levels of cells transfected with lipid-coated
and non-lipid-coated DNA tethered magnetic nanoparticles:
This experiment was designed to assess the ability of the cel-
lular machinery to properly express a protein from a
nanoparticle tethered gene. This experiment reveals the level
of gene expression as measured by fluorescence microscopy,
not to be confused with transfection efficiency, which is dis-
cussed later. Different combinations of DNA, biotin labeling,
MNP, and lipid coating were tested for their effects on gene
expression. The lipid coating has previously been shown to
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Figure 6. Lipid-coated nanocrystal transfected human retinal epithelium cells.  Cells were cultured with lipid-coated nanocrystals tethered to
either EGFP (green in B) or DsRed (red in D) for 48 h or 10 days, respectively. Confocal (A,B) and fluorescence (C,D) microscopy were used
to simultaneously visualize nanocrystals and tethered fluorescent gene expression. The nanocrystals are marked by white arrows and nanocrystal
aggregate is marked with a white arrowhead. A: DIC microscopy. C: Phase contrast microscopy.
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dramatically increase transfection efficiency with naked DNA
[26]. The MNP-DNA-Lipid complex was then delivered to
Huh-7 cells cultured in chamber slides, incubated for 48 h.
The cells were then photographed and the images obtained
were then analyzed with an in house slide based cytometry
software program (written by JNS, UTMB) and the resulting
data presented in Figure 3. All of the values were normalized
to the samples treated with the non-biotinylated GFP fragment
transfected with Lipofectamine 2000. The labeling of the DNA
did not affect the expression of EGFP, as shown in Figure 3
groups B and D. When the DNA was bound to the nanoparticles
(Figure 3 groups E and F), there was a decrease in expression
levels when compared to naked DNA alone (Figure 3 groups
B and C). Figure 3 groups G and J were controls for the con-
struction of the nanoparticles, in that, without a biotin tag the
TAP cannot bind the nanoparticle and should be washed away
during construction. Indeed, we found that the gene expres-
sion levels of Figure 3 groups G and J were equivalent to the
true negative control, Figure 3 group A. The intact pEGFP-C1
plasmid was found to have about two times greater expres-
sion level than the TAP fragment. This is possibly due to the
degradation of the TAP due to the free ends and more substan-
tial transcriptional machinery-binding site.
Transfection efficiencies of lipid-coated magnetic
nanoparticles in adult dog retinal endothelial cells:  Trans-
fection efficiencies were also determined for different amounts
of DNA so that comparisons to naked DNA could be made.
The MNP with lipid coating, were evaluated for dose respon-
siveness and compared to TAP only transfections (Figure 4).
The chosen dosages were nanograms of DNA (100, 200, and
400 ng) transfected over 1 h. The majority (>90%) of the trans-
fection occurs in less than 1 h after exposure to MNP (data not
shown). The percentage of DsRed positive cells was deter-
mined 24 h after transfection. Both the TAP and MNP groups
showed a dose dependent increase in transfection efficiency.
The MNP showed greater average transfection efficiency than
TAP treated cells, in the 200 and 400 ng groups. The MNP
groups were less variable than the TAP treated cells.
Transfection efficiencies of different lipid-coated
nanoparticles:  Transfection efficiency in ADREC was used
to determine the optimal size and core material for future
nanoparticle experiments. Growing cells were treated with SA,
GNP, NC, and MNP all tethered to DNA encoding DsRed and
all coated with lipid. As a control, a DNA only group was also
run. Forty eight h after exposure, the cells exposed to naked
DNA, nanocrystals, and MNP had the highest transfection ef-
ficiency (Figure 5). MNP clearly had the best transfection ef-
ficiency, at 2 times the naked DNA control in the highest dose
(400 ng DNA). All transfection efficiencies were normalized
to DNA alone (400 ng DNA, at 10% of the total cells), be-
cause this is the most appropriate comparison.
Lipid-coated semiconductor nanocrystal transfection of
adult dog retinal endothelial cells:  The ability of lipid-coated
semiconductor based nanocrystals as potential gene carriers
was tested first in ADREC and later in HREC. Confocal im-
aging of these transfected cells (Figure 6) demonstrated that
this nanoparticle was capable of delivering genes to human
cells. One interesting observation was that gene expression
from nanocrystals transfected cells appeared to be very high
in the first 24 h when compared to the DNA alone transfected
cells. This was observed in both ADREC and HREC. The
downside of using nanocrystals in this way is that purification
between construction steps is difficult at best. One of the prob-
lems that has plagued the use of nanocrystals is their tendency
to form aggregates (Figure 6B, arrowhead). When we at-
tempted to purify the nanocrystals by centrifugation, there was
an increase in aggregate formation, so for these studies, the
nanocrystals were not purified away from free DNA.
Quantification of magnetic nanoparticles with TEM:
Transmission electron microscopy was used to determine the
number of MNP in 10 µl of MNP stock solution. The MNP
were bound to biotin-coated polystyrene beads and then em-
bedded for analysis. Ninety bead sections were analyzed for
the presence of bound nanoparticles and bead area. The bead
area was found to have a normal distribution. Because the
thickness of the bead section, the amount of nanoparticles and
beads added to the mixture were known, we were able to de-
termine the number of nanoparticles per µl. Additionally, it
was determined that 3.2 µl of MNP to bind 100 ng of TAP,
therefore, it is possible to enumerate the approximate number
of TAPS bound per MNP, 47. Finally, 128 million nanoparticles
can bind approximately 100 ng of TAP.
DISCUSSION
 These studies have demonstrated that lipid-coated nanocrystals
and MNP can be used to transfect a variety of cell types in-
cluding retinal vascular endothelial cells; however, MNP are
easier to purify. Construction of these nanoparticles using the
streptavidin-biotin conjugation can also be monitored with gel
electrophoresis. Magnetic nanoparticles were the most effi-
cient gene delivery vectors tested. Cells incubated with these
particles showed no visible signs of toxicity (blebbing,
apoptosis, etc.), even though the particles are made of iron.
The MNP offer the most promise of the nanoparticles evalu-
ated.
DNA fragments with 5' or 3' biotin tags were attached to
streptavidin coated magnetic nanoparticles. Free DNA frag-
ments were successfully removed by washing the particles
using a magnetic column. These data indicated that without
lipid coating, there were slightly decreased levels of EGFP
reporter expression when compared to those MNP with lipid.
This may be a result of the number of nanoparticles entering
the nucleus. The addition of lipid to transfection solutions is a
widely recognized method to increase the amount of DNA
that reaches the nucleus. This is also likely to be true for the
MNP.
One important finding is that the DNA tethered magnetic
nanoparticles not coated with lipid were able to successfully
transfect cells in vitro. This result shows that the size range of
these particles is appropriate. Another interesting result is that
cells treated with the DNA tethered magnetic nanoparticles
coated with lipid had expression levels well within range of
those transfected with only labeled DNA fragments. These data
show that we can effectively express gene products from DNA
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tethered to magnetic nanoparticles in either the 5' or 3' con-
figuration. Finally, the unlabeled DNA exposed magnetic
nanoparticles that were subsequently washed with a magnetic
column, did not show any appreciable expression of GFP.
Therefore, the expression we observed with the labeled DNA
and magnetic nanoparticles was from DNA tethered to mag-
netic nanoparticles.
One way to improve the transfection efficiency is to elimi-
nate defective or incomplete nanoparticles prior to delivery.
This scenario would explain the differences in transfection
seen in this study. This further underscores the importance of
nanoparticle purification during construction, one of the main
benefits of using MNP. Secondly, although the cellular mecha-
nisms at work are not known, our results suggest that while
the nanoparticles get close to the nucleus, most never get in
(data not shown). This problem could be solved or at least
ameliorated by the addition of targeting molecules to the
nanoparticle. However, with the addition of another layer
comes the problem of how to purify only the nanoparticle with
all of the layers.
Another benefit of this technology is the ability to trans-
fect cells with low concentrations of DNA. The lower limits
of this technology are often overlooked and researchers tend
to examine maximal doses rather than minimal doses in order
to show the best case scenario. These studies often utilized
conditions that can never be achieved in live animals. We chose
to examine the lower limits of MNP compared to DNA alone
to directly compare the two methods of gene transfer. These
data demonstrate a distinct advantage by the MNP at the 200
and 400 ng doses (Figure 4). This argument is further strength-
ened by the fact that there are about 40 times more DNA par-
ticles in the TAP treated cells. There are thought to be ap-
proximately 47 biotin-binding sites per nanoparticle. If each
copy of DNA in the TAP group is considered a particle ca-
pable of transfection, then, on a per particle basis, the par-
ticles of DNA in the TAP alone group out number the MNP
particles 40 to 1. This means that the MNP are much more
efficient at transfection than TAP. Even so, the critical factor
is the total volume that will be delivered to the eye. Given the
size of the premature infant eye or neonatal dog eye, our model
of ROP, it is possible to inject 50 µl into the vitreous without
having to remove any of the vitreous body. In these studies we
have kept the nanoparticle solutions very dilute. This was pri-
marily due to the costs of the reagents. Therefore, the 50 µl
target volume should be capable of delivering more than
enough nanoparticles, 20 billion MNP or almost 1 trillion cop-
ies of the gene, to an individual eye. Reduction of the
nanoparticle size would allow for more nanoparticles and more
efficient construction could yield an increase in the number of
usable DNA strands per nanoparticle.
Another point of contention in the field of nanoparticle
based gene delivery is the optimal size and material of the
nanoparticles. Our personal experience has guided us to
nanoparticles less than 200 nm in diameter. The current study
included nanoparticles from 0 (naked DNA) to 100 nm. Al-
though the materials were different, there seemed to be a clear
correlation between size and transfection efficiency: the larger
the particle the better the transfection efficiency. This is most
likely a size and mass issue. If the particle is larger and heavier,
there might be a greater chance that the cell and nanoparticle
will be in contact with each other. On the other hand there will
be more particles present as the core size gets smaller, with
the greatest number of particles present in the DNA only group.
With nanoparticles, the smaller the TAP containing
nanoparticles, the less streptavidin that will be present and
consequently fewer DNA particles will be bound. So, by this
formula, increasing the size would decrease the likelihood of
transfection because there would be less nanoparticles per
given volume. We found the opposite to be the case. One pos-
sible scenario is that the addition of multiple TAP copies (47
in the case of MNP) increases the mass of the nanoparticle so
much, that the nanoparticles settle to the bottom. More ex-
periments need to be done in order to clarify this issue of size
versus transfection efficiency.
The issue of nanoparticle toxicity is an important area of
research. One of the more frequent criticisms of MNP in cul-
ture and in animals is the toxicity of the nanoparticle. Specifi-
cally, the major concern revolves around the hypothesis that
the iron in the core of the MNP could induce the formation of
ROS, via Fenton cycling or other mechanisms. We have tested
this hypothesis with CM-H2DCFDA and flow cytometry. This
experiment demonstrated that the levels of ROS, in MNP-
treated cells, were equivalent to those in untreated controls.
This experiment confirms our observation that the cells do
not seem to be harmed by the penetrating MNP. This is likely
due to the fact that the nanoparticles do not readily break down
within the cells. Rather, they appear quite stable during the
course of these experiments. Although this is very promising,
the next step is to evaluate their performance and toxicity in
animal models of ROP.
In summary, multilayered nanoparticles can be constructed
with reasonable ease in a molecular biology laboratory. These
particles have the potential to transfect a multitude of cells,
including those isolated from human sources. Tethered
nanoparticle transfection has the potential to decrease the pos-
sibility of the delivered gene integrating into the host genome.
Additionally this technology can increase the stability of the
DNA in the cellular milieu. These particles also have benefits
over virally delivered genes, like decreased inflammation and
immune response, and the MNP do not induce ROS. One limi-
tation of the MNP reported here is that expression is short-
term and transfection efficiency is low, when compared to other
means of gene delivery (i.e., viral). These shortcomings may
be remedied with better cell entry and nuclear localization
molecules attached to the surface of the nanoparticle. The
nanoparticles investigated offer the possiblity of adding mul-
tiple ordered layers. Perhaps the need to better filter out de-
fective nanoparticles in order to increase functionality is also
important. If these efforts are successful, the potential reward
is huge. The nanoparticle platform is capable of delivering
molecular programming to a single cell and dictating its ac-
tions toward insults. This behavior modification at a molecu-
lar level can be used to prevent disease as it happens. To this
end, we are developing a MNP based system to deliver
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biosensors to the eye which can detect, react and thereby pre-
vent retinopathy of prematurity [17]. The next step is to de-
liver nanoparticles to relevant cells that can detect and respond
to the initial high oxygen insult that initiates ROP.
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